SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001518546-12-000001
Filing Date
2012-01-20
Accepted
2012-01-20 16:37:15
Documents
1
Period of Report
2012-01-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3619
  Complete submission text file 0001518546-12-000001.txt   5067
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451
Business Address
Hart Danny J Jr. (Reporting) CIK: 0001518546 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 12537378